We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05205252
Title A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer. (ARIA)
Acronym ARIA
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Epizyme, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
California Cancer Associates For Research And Excellence, cCARE Santa Fe California 92024 United States Details
Central Care Cancer Center Bolivar Missouri 65613 United States Details
Astera Cancer Center East Brunswick New Jersey 08816 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field